A Phase 1 Study of Alvocidib (Flavopiridol) in Combination With Radiation in Locally Advanced, Non-Operable Pancreatic and Extrahepatic Bile Duct Cancers
Phase of Trial: Phase I
Latest Information Update: 03 Jun 2013
At a glance
- Drugs Alvocidib (Primary) ; Gemcitabine
- Indications Cholangiocarcinoma; Pancreatic cancer
- Focus Adverse reactions
- 10 Jun 2017 Biomarkers information updated
- 24 Mar 2009 Actual end date (August 2008) added as reported by ClinicalTrials.gov.
- 24 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.